7415 related articles for article (PubMed ID: 24600975)
21. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.
Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y
Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576
[TBL] [Abstract][Full Text] [Related]
22. Identification of a melanoma antigen, PRAME, as a BCR/ABL-inducible gene.
Watari K; Tojo A; Nagamura-Inoue T; Nagamura F; Takeshita A; Fukushima T; Motoji T; Tani K; Asano S
FEBS Lett; 2000 Jan; 466(2-3):367-71. PubMed ID: 10682862
[TBL] [Abstract][Full Text] [Related]
23. PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma.
Ercolak V; Paydas S; Bagir E; Ergin M; Seydaoglu G; Celik H; Yavu B; Tanriverdi K; Gunaldi M; Afsar CU; Duman BB
Acta Haematol; 2015; 134(4):199-207. PubMed ID: 26044287
[TBL] [Abstract][Full Text] [Related]
24. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
[TBL] [Abstract][Full Text] [Related]
25. WT1, PRAME, and PR3 mRNA Expression in Acute Myeloid Leukemia (AML).
Steger B; Floro L; Amberger DC; Kroell T; Tischer J; Kolb HJ; Schmetzer HM
J Immunother; 2020; 43(6):204-215. PubMed ID: 32502139
[TBL] [Abstract][Full Text] [Related]
26. Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia.
Ortmann CA; Eisele L; Nückel H; Klein-Hitpass L; Führer A; Dührsen U; Zeschnigk M
Ann Hematol; 2008 Oct; 87(10):809-18. PubMed ID: 18587578
[TBL] [Abstract][Full Text] [Related]
27. Minimal residual disease monitoring and preemptive immunotherapy in myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.
Mo XD; Qin YZ; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
Ann Hematol; 2016 Aug; 95(8):1233-40. PubMed ID: 27302479
[TBL] [Abstract][Full Text] [Related]
28. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
Atanackovic D; Luetkens T; Kloth B; Fuchs G; Cao Y; Hildebrandt Y; Meyer S; Bartels K; Reinhard H; Lajmi N; Hegewisch-Becker S; Schilling G; Platzbecker U; Kobbe G; Schroeder T; Bokemeyer C; Kröger N
Am J Hematol; 2011 Nov; 86(11):918-22. PubMed ID: 21898529
[TBL] [Abstract][Full Text] [Related]
29. Tumor associated antigen PRAME is a marker of favorable prognosis in childhood acute myeloid leukemia patients and modifies the expression of S100A4, Hsp 27, p21, IL-8 and IGFBP-2 in vitro and in vivo.
Tajeddine N; Louis M; Vermylen C; Gala JL; Tombal B; Gailly P
Leuk Lymphoma; 2008 Jun; 49(6):1123-31. PubMed ID: 18452107
[TBL] [Abstract][Full Text] [Related]
30. Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignancies.
Matsushita M; Yamazaki R; Ikeda H; Kawakami Y
Leuk Lymphoma; 2003 Mar; 44(3):439-44. PubMed ID: 12688312
[TBL] [Abstract][Full Text] [Related]
31. PRAME Gene Expression in Acute Leukemia and Its Clinical Significance.
Ding K; Wang XM; Fu R; Ruan EB; Liu H; Shao ZH
Cancer Biol Med; 2012 Mar; 9(1):73-6. PubMed ID: 23691459
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Implication of MIF Gene Expression in Childhood Acute Lymphoblastic Leukemia.
Sharaf-Eldein M; Elghannam D; Elderiny W; Abdel-Malak C
Clin Lab; 2018 Sep; 64(9):1429-1437. PubMed ID: 30274020
[TBL] [Abstract][Full Text] [Related]
33. Correlation of preferentially expressed antigen of melanoma (PRAME) gene expression with clinical characteristics in acute leukemia patients.
Kulkarni NV; Shetty RA; Kumari N S; Shetty VV; Krishna R; Arumugam M; Kalal AA; Shetty P
J Genet Eng Biotechnol; 2022 Jul; 20(1):97. PubMed ID: 35788450
[TBL] [Abstract][Full Text] [Related]
34. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
[TBL] [Abstract][Full Text] [Related]
35. PRAME Gene Copy Number Variation Is Related to Its Expression in Multiple Myeloma.
Yang L; Wang YZ; Zhu HH; Chang Y; Li LD; Chen WM; Long LY; Zhang YH; Liu YR; Lu J; Qin YZ
DNA Cell Biol; 2017 Dec; 36(12):1099-1107. PubMed ID: 28953414
[TBL] [Abstract][Full Text] [Related]
36. PRAME expression in hairy cell leukemia.
Arons E; Suntum T; Margulies I; Yuan C; Stetler-Stevenson M; Kreitman RJ
Leuk Res; 2008 Sep; 32(9):1400-6. PubMed ID: 18295331
[TBL] [Abstract][Full Text] [Related]
37. Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia.
Steinbach D; Schramm A; Eggert A; Onda M; Dawczynski K; Rump A; Pastan I; Wittig S; Pfaffendorf N; Voigt A; Zintl F; Gruhn B
Clin Cancer Res; 2006 Apr; 12(8):2434-41. PubMed ID: 16638849
[TBL] [Abstract][Full Text] [Related]
38. PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes.
Qin YZ; Zhu HH; Liu YR; Wang YZ; Shi HX; Lai YY; Xu LP; Liu DH; Jiang Q; Li LD; Jiang B; Liu KY; Huang XJ
Leuk Lymphoma; 2013 Jul; 54(7):1442-9. PubMed ID: 23110703
[TBL] [Abstract][Full Text] [Related]
39. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
40. PRAME induces apoptosis and inhibits proliferation of leukemic cells in vitro and in vivo.
Xu Y; Yue Q; Wei H; Pan G
Int J Clin Exp Pathol; 2015; 8(11):14549-55. PubMed ID: 26823776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]